- Experts: Industry to benefit from focused follow-ups, major deficiency letters in MDUFA VI<p>Industry experts say the draft commitment letter for the next Medical Device User Fee Amendments (MDUFA VI) program negotiated by the US Food and Drug Administration (FDA) and the medtech indust…raps · 11d ago↗ source
- STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patentsA group of AIDS activists obtained an R&D pact at the heart of a settlement between the U.S. government and Gilead Sciences over patents for HIV prevention.STAT · 11d ago↗ source
- Freenome colorectal cancer test data improve on earlier results<figure><div><img src="https://imgproxy.divecdn.com/t2eSQFnULTRPQ6pHoF74ilRTdrAlEvvFROsITsihAlw/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMDUzMDQ1NTczLmpwZ…